• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔波特综合征:实现早期诊断和治疗。

Alport Syndrome: Achieving Early Diagnosis and Treatment.

机构信息

Pediatric Nephrology, University of Minnesota Medical School, Minneapolis, MN.

出版信息

Am J Kidney Dis. 2021 Feb;77(2):272-279. doi: 10.1053/j.ajkd.2020.03.026. Epub 2020 Jul 22.

DOI:10.1053/j.ajkd.2020.03.026
PMID:32712016
Abstract

Alport syndrome is a genetically and phenotypically heterogeneous disorder of glomerular, cochlear, and ocular basement membranes resulting from mutations in the collagen IV genes COL4A3, COL4A4, and COL4A5. Alport syndrome can be transmitted as an X-linked, autosomal recessive, or autosomal dominant disorder. Individuals with Alport syndrome have a significant lifetime risk for kidney failure, as well as sensorineural deafness and ocular abnormalities. The availability of effective intervention for Alport syndrome-related kidney disease makes early diagnosis crucial, but this can be impeded by the genotypic and phenotypic complexity of the disorder. This review presents an approach to enhancing early diagnosis and achieving optimal outcomes.

摘要

阿尔波特综合征是一种遗传性和表型异质性疾病,影响肾小球、耳蜗和眼部基底膜,由 COL4A3、COL4A4 和 COL4A5 基因突变引起。阿尔波特综合征可作为 X 连锁、常染色体隐性或常染色体显性遗传疾病进行传递。患有阿尔波特综合征的个体一生中发生肾衰竭、感音神经性耳聋和眼部异常的风险显著增加。由于针对与阿尔波特综合征相关的肾脏疾病的有效干预措施已经出现,因此早期诊断至关重要,但由于该疾病的基因型和表型复杂性,这可能会受到阻碍。本综述提出了一种改进早期诊断和实现最佳结果的方法。

相似文献

1
Alport Syndrome: Achieving Early Diagnosis and Treatment.阿尔波特综合征:实现早期诊断和治疗。
Am J Kidney Dis. 2021 Feb;77(2):272-279. doi: 10.1053/j.ajkd.2020.03.026. Epub 2020 Jul 22.
2
Familial hematuria: A review.家族性血尿:综述
Medicina (Kaunas). 2017;53(1):1-10. doi: 10.1016/j.medici.2017.01.002. Epub 2017 Jan 31.
3
Guidelines for Genetic Testing and Management of Alport Syndrome.《Alport 综合征的基因检测与管理指南》。
Clin J Am Soc Nephrol. 2022 Jan;17(1):143-154. doi: 10.2215/CJN.04230321. Epub 2021 Dec 20.
4
Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.常染色体显性遗传性奥尔波特综合征患者的遗传、临床及病理背景
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1441-1449. doi: 10.2215/CJN.01000116. Epub 2016 Jun 8.
5
[Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].[奥尔波特综合征:与IV型胶原链编码基因突变相关的遗传性肾病]
Nephrol Ther. 2016 Dec;12(7):544-551. doi: 10.1016/j.nephro.2016.09.001. Epub 2016 Nov 2.
6
Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.IV型胶原肾病的常染色体显性遗传形式存在于临床病理诊断困难的遗传性肾炎患者中。
Nephrology (Carlton). 2018 Oct;23(10):940-947. doi: 10.1111/nep.13115.
7
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group.Alport 综合征:IV 型胶原 α345 遗传疾病的统一分类:Alport 综合征分类工作组的立场文件。
Kidney Int. 2018 May;93(5):1045-1051. doi: 10.1016/j.kint.2017.12.018. Epub 2018 Mar 16.
8
Renal, auricular, and ocular outcomes of Alport syndrome and their current management.Alport 综合征的肾脏、耳部和眼部结局及其当前的治疗方法。
Pediatr Nephrol. 2018 Aug;33(8):1309-1316. doi: 10.1007/s00467-017-3784-3. Epub 2017 Sep 1.
9
Endothelial cell-specific collagen type IV-α expression does not rescue Alport syndrome in Col4a3 mice.内皮细胞特异性IV型胶原蛋白α表达不能挽救Col4a3小鼠的奥尔波特综合征。
Am J Physiol Renal Physiol. 2019 May 1;316(5):F830-F837. doi: 10.1152/ajprenal.00556.2018. Epub 2019 Feb 6.
10
Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.葡萄牙的IV型胶原相关肾病:25个家系的致病性COL4A3和COL4A4突变及临床特征
Clin Genet. 2015 Nov;88(5):456-61. doi: 10.1111/cge.12521. Epub 2014 Nov 10.

引用本文的文献

1
Targeted exome sequencing for molecular diagnosis of pediatric Alport syndrome in Southwest China.中国西南地区儿童遗传性肾炎分子诊断的靶向外显子组测序
Front Genet. 2025 Aug 29;16:1580864. doi: 10.3389/fgene.2025.1580864. eCollection 2025.
2
A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN.一例罕见的双重肾小球病理情况:奥尔波特综合征和免疫复合物介导的膜增生性肾小球肾炎。
BMC Nephrol. 2025 Sep 3;26(1):514. doi: 10.1186/s12882-025-04400-z.
3
High Prevalence of Autosomal Recessive Alport Syndrome in Roma Population of Eastern Slovakia.
斯洛伐克东部罗姆人群体中常染色体隐性遗传性阿尔波特综合征的高患病率。
Biomedicines. 2025 Aug 12;13(8):1960. doi: 10.3390/biomedicines13081960.
4
Novel COL4A3-COL4A5 variants and digenic inheritance in pediatric Alport syndrome from Southwestern China.中国西南地区小儿Alport综合征中的新型COL4A3-COL4A5变异体及双基因遗传
Sci Rep. 2025 Aug 25;15(1):31313. doi: 10.1038/s41598-025-17027-9.
5
Lipidomics Unveils Critical Lipid Pathway Shifts in Alport Syndrome.脂质组学揭示了阿尔波特综合征中关键脂质途径的变化。
Kidney Int Rep. 2025 May 26;10(8):2805-2820. doi: 10.1016/j.ekir.2025.05.034. eCollection 2025 Aug.
6
A comprehensive splicing characterization of COL4A5 mutations and prognostic significance in a single cohort with X-linked alport syndrome.X连锁Alport综合征单一队列中COL4A5突变的全面剪接特征及预后意义
Front Genet. 2025 Jun 11;16:1564343. doi: 10.3389/fgene.2025.1564343. eCollection 2025.
7
The complexity of kidney disease secondary to collagen IV variants: insights into phenotypic variability from a large Sicilian pedigree.胶原IV变体继发的肾脏疾病的复杂性:来自一个大型西西里家族系谱对表型变异性的见解。
J Nephrol. 2025 Jun 16. doi: 10.1007/s40620-025-02321-6.
8
Proteinuria in Alport Syndrome: Treatment With Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors.Alport综合征中的蛋白尿:使用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂进行治疗
Cureus. 2025 May 4;17(5):e83455. doi: 10.7759/cureus.83455. eCollection 2025 May.
9
Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease.X染色体的基因分析将基因座与帕金森病的进展相关联。
Mov Disord. 2025 Jun 3. doi: 10.1002/mds.30252.
10
The heterozygous mutation c.817-1G>A causes Alport syndrome in a Chinese family: a case report.杂合突变c.817-1G>A在中国一个家族中导致遗传性肾炎:病例报告。
Front Pediatr. 2025 May 8;13:1533638. doi: 10.3389/fped.2025.1533638. eCollection 2025.